User profiles for Igor F. Tsigelny
Igor TsigelnyProfessor of Neurosciences, UC San Diego Verified email at ucsd.edu Cited by 8165 |
[HTML][HTML] Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases
Background Misfolding and pathological aggregation of neuronal proteins has been proposed
to play a critical role in the pathogenesis of neurodegenerative disorders. Alzheimer's …
to play a critical role in the pathogenesis of neurodegenerative disorders. Alzheimer's …
Genomic landscape of cell-free DNA in patients with colorectal cancer
…, RB Lanman, AA Talasaz, IF Tsigelny… - Cancer discovery, 2018 - AACR
“Liquid biopsy” approaches analyzing cell-free DNA (cfDNA) from the blood of patients with
cancer are increasingly utilized in clinical practice. However, it is not yet known whether …
cancer are increasingly utilized in clinical practice. However, it is not yet known whether …
Role of α‐synuclein penetration into the membrane in the mechanisms of oligomer pore formation
IF Tsigelny, Y Sharikov, W Wrasidlo… - The FEBS …, 2012 - Wiley Online Library
Parkinson’s disease (PD) and dementia with Lewy bodies are common disorders of the aging
population and characterized by the progressive accumulation of α‐synuclein (α‐syn) in …
population and characterized by the progressive accumulation of α‐synuclein (α‐syn) in …
Dynamics of α‐synuclein aggregation and inhibition of pore‐like oligomer development by β‐synuclein
IF Tsigelny, P Bar‐On, Y Sharikov, L Crews… - The FEBS …, 2007 - Wiley Online Library
Accumulation of α‐synuclein resulting in the formation of oligomers and protofibrils has been
linked to Parkinson's disease and Lewy body dementia. In contrast, β‐synuclein (β‐syn), a …
linked to Parkinson's disease and Lewy body dementia. In contrast, β‐synuclein (β‐syn), a …
Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1)
…, MA Nagle, VL Kouznetsova, IF Tsigelny… - Journal of proteome …, 2011 - ACS Publications
Untargeted metabolomics on the plasma and urine from wild-type and organic anion
transporter-1 (Oat1/Slc22a6) knockout mice identified a number of physiologically important …
transporter-1 (Oat1/Slc22a6) knockout mice identified a number of physiologically important …
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease
W Wrasidlo, IF Tsigelny, DL Price, G Dutta… - Brain, 2016 - academic.oup.com
Abnormal accumulation and propagation of the neuronal protein α-synuclein has been
hypothesized to underlie the pathogenesis of Parkinson’s disease, dementia with Lewy bodies …
hypothesized to underlie the pathogenesis of Parkinson’s disease, dementia with Lewy bodies …
Artificial intelligence in drug combination therapy
IF Tsigelny - Briefings in bioinformatics, 2019 - academic.oup.com
… Igor F Tsigelny Igor F Tsigelny … Tsigelny is an expert in structural biology, molecular
modeling, bioinformatics, structure-based drug design and personalized medicine. He published >…
modeling, bioinformatics, structure-based drug design and personalized medicine. He published >…
Identification of Substituted Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands
…, S Yao, RI Tawatao, B Crain, IF Tsigelny… - Journal of medicinal …, 2013 - ACS Publications
A cell-based high-throughput screen to identify small molecular weight stimulators of the
innate immune system revealed substituted pyrimido[5,4-b]indoles as potent NFκB activators. …
innate immune system revealed substituted pyrimido[5,4-b]indoles as potent NFκB activators. …
Next‐generation sequencing of circulating tumor DNA reveals frequent alterations in advanced hepatocellular carcinoma
Background Because imaging has a high sensitivity to diagnose hepatocellular carcinoma (HCC)
and tissue biopsies carry risks such as bleeding, the latter are often not performed in …
and tissue biopsies carry risks such as bleeding, the latter are often not performed in …
[HTML][HTML] Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs
…, A Zhang, M Tatineni, MA Miller, IF Tsigelny - PeerJ, 2020 - peerj.com
Using the crystal structure of SARS-CoV-2 papain-like protease (PL pro) as a template, we
developed a pharmacophore model of functional centers of the PL pro inhibitor-binding …
developed a pharmacophore model of functional centers of the PL pro inhibitor-binding …